Loading...

Cooper Companies

NYSE:COO
Snowflake Description

Proven track record with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
COO
NYSE
$14B
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

The Cooper Companies, Inc. operates as a medical device company worldwide. The last earnings update was 71 days ago. More info.


Add to Portfolio Compare Print
COO Share Price and Events
7 Day Returns
-0.2%
NYSE:COO
-3.8%
US Medical Equipment
-3.9%
US Market
1 Year Returns
26%
NYSE:COO
10%
US Medical Equipment
1.4%
US Market
COO Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Cooper Companies (COO) -0.2% 0.6% 4.2% 26% 82.5% 123.8%
US Medical Equipment -3.8% -3.9% -1.1% 10% 54.1% 90.5%
US Market -3.9% -3.6% 1.8% 1.4% 35.8% 40.8%
1 Year Return vs Industry and Market
  • COO outperformed the Medical Equipment industry which returned 10% over the past year.
  • COO outperformed the Market in United States of America which returned 1.4% over the past year.
Price Volatility
COO
Industry
5yr Volatility vs Market

Value

 Is Cooper Companies undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Cooper Companies to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Cooper Companies.

NYSE:COO Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 15 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.7%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NYSE:COO
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.9
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.896 (1 + (1- 21%) (14.85%))
1.001
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.001 * 5.96%)
8.69%

Discounted Cash Flow Calculation for NYSE:COO using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Cooper Companies is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NYSE:COO DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 8.69%)
2019 590.11 Analyst x3 542.90
2020 591.02 Analyst x3 500.25
2021 696.00 Analyst x2 541.98
2022 791.50 Analyst x1 567.05
2023 862.16 Analyst x1 568.26
2024 920.83 Est @ 6.81% 558.39
2025 972.23 Est @ 5.58% 542.40
2026 1,018.19 Est @ 4.73% 522.60
2027 1,060.21 Est @ 4.13% 500.65
2028 1,099.53 Est @ 3.71% 477.68
Present value of next 10 years cash flows $5,322.17
NYSE:COO DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $1,099.53 × (1 + 2.73%) ÷ (8.69% – 2.73%)
$18,938.27
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $18,938.27 ÷ (1 + 8.69%)10
$8,227.53
NYSE:COO Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $5,322.17 + $8,227.53
$13,549.70
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $13,549.70 / 49.37
$274.43
NYSE:COO Discount to Share Price
Calculation Result
Value per share (USD) From above. $274.43
Current discount Discount to share price of $290.76
= -1 x ($290.76 - $274.43) / $274.43
-6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Cooper Companies is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Cooper Companies's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Cooper Companies's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:COO PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-01-31) in USD $7.43
NYSE:COO Share Price ** NYSE (2019-05-15) in USD $290.76
United States of America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 38.98x
United States of America Market PE Ratio Median Figure of 3,087 Publicly-Listed Companies 17.79x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Cooper Companies.

NYSE:COO PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:COO Share Price ÷ EPS (both in USD)

= 290.76 ÷ 7.43

39.13x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cooper Companies is overvalued based on earnings compared to the US Medical Equipment industry average.
  • Cooper Companies is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Cooper Companies's expected growth come at a high price?
Raw Data
NYSE:COO PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 39.13x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 15 Analysts
17.5%per year
United States of America Medical Equipment Industry PEG Ratio Median Figure of 55 Publicly-Listed Medical Equipment Companies 2.21x
United States of America Market PEG Ratio Median Figure of 2,113 Publicly-Listed Companies 1.52x

*Line of best fit is calculated by linear regression .

NYSE:COO PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 39.13x ÷ 17.5%

2.24x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cooper Companies is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Cooper Companies's assets?
Raw Data
NYSE:COO PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-01-31) in USD $69.48
NYSE:COO Share Price * NYSE (2019-05-15) in USD $290.76
United States of America Medical Equipment Industry PB Ratio Median Figure of 182 Publicly-Listed Medical Equipment Companies 4.28x
United States of America Market PB Ratio Median Figure of 5,195 Publicly-Listed Companies 1.83x
NYSE:COO PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:COO Share Price ÷ Book Value per Share (both in USD)

= 290.76 ÷ 69.48

4.18x

* Primary Listing of Cooper Companies.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cooper Companies is good value based on assets compared to the US Medical Equipment industry average.
X
Value checks
We assess Cooper Companies's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Cooper Companies has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Cooper Companies expected to perform in the next 1 to 3 years based on estimates from 15 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
17.5%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Cooper Companies expected to grow at an attractive rate?
  • Cooper Companies's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Cooper Companies's earnings growth is expected to exceed the United States of America market average.
  • Cooper Companies's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:COO Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:COO Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 15 Analysts 17.5%
NYSE:COO Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 15 Analysts 6.2%
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.5%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 8.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:COO Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 15 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:COO Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-10-31
2022-10-31 3,193 1
2021-10-31 3,013 923 643 7
2020-10-31 2,832 822 556 15
2019-10-31 2,656 761 475 15
NYSE:COO Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-01-31 2,571 745 366
2018-10-31 2,533 669 140
2018-07-31 2,443 631 128
2018-04-30 2,339 551 131
2018-01-31 2,230 511 175
2017-10-31 2,139 594 373
2017-07-31 2,096 588 345
2017-04-30 2,055 562 329
2017-01-31 2,016 529 298
2016-10-31 1,967 510 274
2016-07-31 1,904 421 250
2016-04-30 1,851 388 207

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Cooper Companies's earnings are expected to grow by 17.5% yearly, however this is not considered high growth (20% yearly).
  • Cooper Companies's revenue is expected to grow by 6.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:COO Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 15 Analyst Estimates (S&P Global) See Below

All data from Cooper Companies Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:COO Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-10-31
2022-10-31 13.15 13.15 13.15 1.00
2021-10-31 12.60 14.20 11.07 6.00
2020-10-31 11.05 12.55 9.27 11.00
2019-10-31 9.41 10.51 7.55 11.00
NYSE:COO Past Financials Data
Date (Data in USD Millions) EPS *
2019-01-31 7.43
2018-10-31 2.85
2018-07-31 2.61
2018-04-30 2.67
2018-01-31 3.57
2017-10-31 7.63
2017-07-31 7.05
2017-04-30 6.75
2017-01-31 6.13
2016-10-31 5.65
2016-07-31 5.16
2016-04-30 4.27

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Cooper Companies is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Cooper Companies's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Cooper Companies has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Cooper Companies performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Cooper Companies's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Cooper Companies's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • Cooper Companies's 1-year earnings growth exceeds its 5-year average (109.4% vs -3.4%)
  • Cooper Companies's earnings growth has exceeded the US Medical Equipment industry average in the past year (109.4% vs 31.9%).
Earnings and Revenue History
Cooper Companies's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Cooper Companies Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:COO Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-01-31 2,570.90 365.60 977.90 87.00
2018-10-31 2,532.80 139.90 964.60 84.80
2018-07-31 2,442.80 127.80 916.20 80.70
2018-04-30 2,338.80 130.60 872.30 75.70
2018-01-31 2,229.90 174.60 822.60 71.70
2017-10-31 2,139.00 372.90 785.30 69.20
2017-07-31 2,096.10 344.80 756.20 68.30
2017-04-30 2,054.90 329.10 739.40 66.70
2017-01-31 2,016.30 298.30 725.50 66.60
2016-10-31 1,966.80 273.90 710.90 65.40
2016-07-31 1,903.74 250.08 678.74 63.26
2016-04-30 1,850.61 207.13 665.63 63.76
2016-01-31 1,801.49 193.74 655.71 63.68
2015-10-31 1,797.10 203.50 661.00 65.00
2015-07-31 1,809.52 197.63 658.52 66.61
2015-04-30 1,780.33 240.75 654.84 66.28
2015-01-31 1,757.97 259.19 647.66 65.96
2014-10-31 1,717.78 269.86 638.62 65.66
2014-07-31 1,660.83 296.47 631.74 63.90
2014-04-30 1,639.64 297.35 622.68 62.69
2014-01-31 1,610.67 293.33 617.57 60.89
2013-10-31 1,587.73 296.15 610.14 58.83
2013-07-31 1,570.57 310.67 600.95 57.13
2013-04-30 1,537.47 288.60 592.64 55.42
2013-01-31 1,498.72 268.38 578.91 53.96
2012-10-31 1,445.14 248.34 564.90 51.73
2012-07-31 1,409.74 233.06 542.23 49.35

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Cooper Companies has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Cooper Companies used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.
  • Cooper Companies has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Cooper Companies's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Cooper Companies has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Cooper Companies's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Cooper Companies's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Cooper Companies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Cooper Companies's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Cooper Companies's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Cooper Companies Company Filings, last reported 3 months ago.

NYSE:COO Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-01-31 3,425.50 2,132.40 146.60
2018-10-31 3,307.80 2,022.80 77.70
2018-07-31 3,226.60 2,294.20 155.60
2018-04-30 3,188.00 2,483.70 164.90
2018-01-31 3,156.40 2,402.50 91.70
2017-10-31 3,175.80 1,172.70 88.80
2017-07-31 3,093.30 1,213.40 46.00
2017-04-30 2,939.80 1,386.90 121.30
2017-01-31 2,819.40 1,424.50 91.10
2016-10-31 2,695.90 1,333.70 100.80
2016-07-31 2,737.40 1,444.07 62.61
2016-04-30 2,744.78 1,441.37 44.46
2016-01-31 2,606.73 1,377.32 16.05
2015-10-31 2,673.90 1,349.21 16.43
2015-07-31 2,693.94 1,307.86 17.01
2015-04-30 2,615.74 1,347.71 17.91
2015-01-31 2,516.99 1,395.34 16.43
2014-10-31 2,588.44 1,382.35 25.22
2014-07-31 2,676.28 348.24 173.79
2014-04-30 2,562.08 336.12 82.66
2014-01-31 2,453.91 346.84 28.83
2013-10-31 2,423.49 346.36 77.39
2013-07-31 2,437.64 245.83 25.48
2013-04-30 2,336.50 323.40 14.44
2013-01-31 2,249.55 411.27 14.45
2012-10-31 2,213.16 377.61 12.84
2012-07-31 2,096.65 484.38 12.73
  • Cooper Companies's level of debt (62.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (14.1% vs 62.3% today).
  • Debt is well covered by operating cash flow (34.9%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 6.1x coverage).
X
Financial health checks
We assess Cooper Companies's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Cooper Companies has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Cooper Companies's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.02%
Current annual income from Cooper Companies dividends. Estimated to be 0.02% next year.
If you bought $2,000 of Cooper Companies shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Cooper Companies's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.46%).
  • Cooper Companies's dividend is below the markets top 25% of dividend payers in United States of America (3.71%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:COO Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 15 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1997 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:COO Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-10-31
2022-10-31
2021-10-31 0.06 2.00
2020-10-31 0.06 3.00
2019-10-31 0.06 3.00
NYSE:COO Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-01-07 0.060 0.021
2018-12-21 0.060 0.024
2018-12-06 0.060 0.024
2018-07-12 0.060 0.023
2018-06-08 0.060 0.025
2018-06-07 0.060 0.026
2018-01-04 0.060 0.026
2017-12-22 0.060 0.027
2017-12-07 0.060 0.026
2017-09-01 0.060 0.025
2017-08-31 0.060 0.025
2017-06-02 0.060 0.025
2017-06-01 0.060 0.026
2017-01-05 0.060 0.031
2016-12-22 0.060 0.034
2016-12-08 0.060 0.034
2016-07-07 0.060 0.034
2016-06-03 0.060 0.036
2016-06-02 0.060 0.036
2016-01-07 0.060 0.041
2015-12-18 0.060 0.045
2015-07-09 0.060 0.039
2015-06-05 0.060 0.034
2015-06-04 0.060 0.034
2015-01-08 0.060 0.034
2014-12-19 0.060 0.037
2014-12-04 0.060 0.037
2014-07-10 0.060 0.038
2014-06-06 0.060 0.043
2014-06-05 0.060 0.045
2014-01-08 0.060 0.046
2013-12-20 0.060 0.048
2013-12-05 0.060 0.049
2013-07-11 0.060 0.046
2013-06-07 0.060 0.050
2013-06-06 0.060 0.052
2013-01-08 0.060 0.057
2012-12-20 0.060 0.064
2012-07-12 0.060 0.068
2012-06-08 0.060 0.076
2012-06-07 0.060 0.076
2012-01-05 0.060 0.075
2011-12-16 0.060 0.086
2011-12-08 0.060 0.092
2011-07-13 0.060 0.085
2011-06-03 0.060 0.078
2011-06-02 0.060 0.082
2011-01-06 0.060 0.090
2010-12-17 0.060 0.106
2010-12-07 0.060 0.104
2010-07-09 0.060 0.133
2010-06-04 0.060 0.154
2010-06-03 0.060 0.160
2010-01-08 0.060 0.158
2009-12-21 0.060 0.157
2009-12-08 0.060 0.163
2009-07-10 0.060 0.206
2009-06-05 0.060 0.229
2009-06-04 0.060 0.207

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cooper Companies is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.
  • Cooper Companies is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Cooper Companies's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Cooper Companies's dividends as it is not paying a notable one for United States of America.
Future Payout to shareholders
  • No need to calculate the sustainability of Cooper Companies's dividends in 3 years as they are not expected to pay a notable one for United States of America.
X
Income/ dividend checks
We assess Cooper Companies's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Cooper Companies afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Cooper Companies has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Cooper Companies's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Albert White
COMPENSATION $6,067,120
AGE 48
TENURE AS CEO 1 years
CEO Bio

Mr. Albert G. White, III, has been President, Director and Chief Executive Officer of The Cooper Companies since May 1, 2018. Mr. White served as Chief Financial Officer of The Cooper Companies Inc. since November 1, 2016 until May 1, 2018. Mr. White served as the Chief Strategic Officer of The Cooper Companies Inc. since July 15, 2011 until May 1, 2018 and its Executive Vice President since December 2015 until May 1, 2018. He served as Chief Strategy Officer and Vice President of Investor Relations of CooperSurgical Inc., a subsidiary of The Cooper Companies Inc. He served as Senior Vice President of The Cooper Companies Inc. from November 2014 to December 22, 2015. Mr. White served as Vice President of The Cooper Companies Inc., from April 2006 to December 2012. He served as Treasurer and Vice President of Investor Relations of CooperSurgical Inc. He served as a Vice President of Investor Relations at The Cooper Companies Inc. since November 2007 until March 2013. He served as Treasurer at The Cooper Companies Inc. from April 10, 2006 to December 31, 2012. He served as Vice President of The Cooper Companies Inc. from April 10, 2006 to November 2007. Mr. White has been Cooper's primary relationship banker for 10 years. His experience includes corporate financings, acquisitions, private placements, strategic capital structure design and ancillary credit and non-credit products in both domestic and international markets. He joined Cooper from corporate and investment banking at Key Bank Capital Markets, where he served as Director in the Consumer Group and held number of leadership positions within KeyBank National Association for eight years. Mr. White received a Bachelor's Degree in Finance and a Master of Business Administration from Virginia Tech.

CEO Compensation
  • Albert's compensation has increased by more than 20% in the past year.
  • Albert's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Cooper Companies management team in years:

1.2
Average Tenure
51
Average Age
  • The average tenure for the Cooper Companies management team is less than 2 years, this suggests a new team.
Management Team

Albert White

TITLE
President
COMPENSATION
$6M
AGE
48
TENURE
1 yrs

Brian Andrews

TITLE
Senior VP
COMPENSATION
$1M
AGE
39
TENURE
1 yrs

Dan McBride

TITLE
Executive VP & COO
COMPENSATION
$4M
AGE
54
TENURE
5.5 yrs

Holly Sheffield

TITLE
Executive VP & Chief Strategy Officer
COMPENSATION
$3M
AGE
47
TENURE
0.9 yrs

Bob Auerbach

TITLE
President of Coopersurgical Inc
COMPENSATION
$1M
AGE
57
TENURE
1.1 yrs

Agostino Ricupati

TITLE
Senior VP of Finance & Tax and Chief Accounting Officer
COMPENSATION
$1M
AGE
51
TENURE
1.6 yrs

Kim Duncan

TITLE
Vice President of Investor Relations & Administration

Randy Golden

TITLE
VP, General Counsel & Secretary
AGE
56
TENURE
5.3 yrs

Juan Aragón

TITLE
President of CooperVision Specialty EyeCare Division
TENURE
1.3 yrs
Board of Directors Tenure

Average tenure and age of the Cooper Companies board of directors in years:

13.3
Average Tenure
71
Average Age
  • The average tenure for the Cooper Companies board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Tom Bender

TITLE
Chairman
COMPENSATION
$492K
AGE
79
TENURE
16.8 yrs

Albert White

TITLE
President
COMPENSATION
$6M
AGE
48
TENURE
1 yrs

Allan Rubenstein

TITLE
Vice Chairman & Lead Director
COMPENSATION
$378K
AGE
73
TENURE
16.8 yrs

Michael Kalkstein

TITLE
Independent Director
COMPENSATION
$380K
AGE
75
TENURE
27.3 yrs

Jody Lindell

TITLE
Independent Director
COMPENSATION
$378K
AGE
67
TENURE
13.3 yrs

Robert Weiss

TITLE
Non-Independent Director
COMPENSATION
$6M
AGE
71
TENURE
23.3 yrs

Gary Petersmeyer

TITLE
Independent Director
COMPENSATION
$364K
AGE
71
TENURE
6.3 yrs

Colleen Jay

TITLE
Independent Director
COMPENSATION
$362K
AGE
55
TENURE
3.1 yrs

Bill Kozy

TITLE
Independent Director
COMPENSATION
$358K
AGE
66
TENURE
3.1 yrs
Who owns this company?
Recent Insider Trading
  • Cooper Companies insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
02. Apr 19 Sell Jody Lindell Individual 01. Apr 19 01. Apr 19 -2,943 $296.80 $-871,948
02. Apr 19 Sell Agostino Ricupati Individual 29. Mar 19 29. Mar 19 -2,400 $296.14 $-710,722
27. Mar 19 Sell Brian Andrews Individual 25. Mar 19 25. Mar 19 -1,648 $293.28 $-483,325
14. Mar 19 Sell Robert Auerbach Individual 12. Mar 19 12. Mar 19 -2,272 $292.22 $-663,926
12. Mar 19 Sell Gary Petersmeyer Individual 08. Mar 19 08. Mar 19 -799 $286.88 $-229,217
12. Mar 19 Sell Michael Kalkstein Individual 11. Mar 19 11. Mar 19 -3,570 $288.55 $-1,030,121
12. Dec 18 Buy Allan Rubenstein Individual 10. Dec 18 10. Dec 18 348 $241.60 $84,075
01. Oct 18 Sell Randal Golden Individual 27. Sep 18 27. Sep 18 -1,731 $275.86 $-477,510
13. Sep 18 Sell Allan Rubenstein Individual 13. Sep 18 13. Sep 18 -1,500 $265.37 $-398,055
02. Jul 18 Sell Daniel McBride Individual 29. Jun 18 29. Jun 18 -2,147 $235.13 $-504,820
25. Jun 18 Sell Gary Petersmeyer Individual 22. Jun 18 22. Jun 18 -430 $234.33 $-100,764
19. Jun 18 Sell Allan Rubenstein Individual 15. Jun 18 15. Jun 18 -1,000 $235.13 $-235,130
X
Management checks
We assess Cooper Companies's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Cooper Companies has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is It Time To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?

Today we're going to take a look at the well-established The Cooper Companies, Inc. … saw its share price hover around a small range of $272.82 to $297.59 over the last few weeks? … Let’s take a look at Cooper Companies’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change

Simply Wall St -

Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)

I will use the Discounted Cash Flow (DCF) model! … If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. … We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows

Simply Wall St -

The Cooper Companies, Inc. (NYSE:COO): Can Growth Justify Its April Share Price?

Check out our latest analysis for Cooper Companies? … What can we expect from Cooper Companies in the future. … One reason why investors are attracted to COO is the high growth potential in the near future

Simply Wall St -

How Good Is The Cooper Companies, Inc. (NYSE:COO) At Creating Shareholder Value?

In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business. … What is Return On Capital Employed (ROCE)? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.

Simply Wall St -

Is The Cooper Companies, Inc.'s (NYSE:COO) Balance Sheet A Threat To Its Future?

Let’s take a look at Cooper Companies’s leverage and assess its financial strength to get an idea of their ability to fund strategic acquisitions and grow through cyclical pressures. … Remember this is a very top-level look that focuses exclusively on financial health, so I recommend a deeper analysis … View our latest analysis for Cooper Companies

Simply Wall St -

Did Business Growth Power Cooper Companies's Share Price Gain of 128%?

One flawed but reasonable way to assess how sentiment around a company has changed, is to compare the earnings per share (EPS) with the share price. … Cooper Companies's earnings per share are down 14% per year, despite strong share price performance over five years. … In contrast revenue growth of 8.8% per year is probably viewed as evidence that Cooper Companies is growing, a real positive.

Simply Wall St -

Based On Its ROE, Is The Cooper Companies, Inc. (NYSE:COO) A High Quality Stock?

This article is for those who would like to learn about Return On Equity (ROE). … One way to conceptualize this, is that for each $1 of shareholders' equity it has, the company made $0.042 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Despite Its High P/E Ratio, Is The Cooper Companies, Inc. (NYSE:COO) Still Undervalued?

Based on the last twelve months, Cooper Companies's P/E ratio is 90.64. … How Do I Calculate Cooper Companies's Price To Earnings Ratio … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

Is There Now An Opportunity In The Cooper Companies, Inc. (NYSE:COO)?

saw significant share price movement during recent months on the NYSE, rising to highs of $281.66 and falling to the lows of $236.78. … Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price? … A question to answer is whether Cooper Companies's current trading price of $236.78 reflective of the actual value of the?

Simply Wall St -

Did The Cooper Companies Inc (NYSE:COO) Insiders Sell Shares?

That means that an insider was selling shares at below the current price (US$275). … All up, insiders sold more shares in Cooper Companies than they bought, over the last year … It's not ideal to see that insiders have sold at around the current price of US$275

Simply Wall St -

Company Info

Description

The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier preimplantation genetic screening, preimplantation genetic diagnosis, and screening used in IVF process; micro pipettes; IVF medical devices and systems; and PARAGARD, a contraceptive option. It markets its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.

Details
Name: The Cooper Companies, Inc.
COO
Exchange: NYSE
Founded: 1980
$14,356,024,074
49,374,137
Website: http://www.coopercos.com
Address: The Cooper Companies, Inc.
6140 Stoneridge Mall Road,
Suite 590,
Pleasanton,
California, 94588,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE COO Common Stock New York Stock Exchange US USD 21. Jan 1983
DB CP6 Common Stock Deutsche Boerse AG DE EUR 21. Jan 1983
LSE 0I3I Common Stock London Stock Exchange GB USD 21. Jan 1983
BMV COO * Common Stock Bolsa Mexicana de Valores MX MXN 21. Jan 1983
Number of employees
Current staff
Staff numbers
12,000
Cooper Companies employees.
Industry
Health Care Supplies
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/16 01:20
End of day share price update: 2019/05/15 00:00
Last estimates confirmation: 2019/04/18
Last earnings filing: 2019/03/06
Last earnings reported: 2019/01/31
Last annual earnings reported: 2018/10/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.